CSP
1 min read
22

Nordea Bank Abp: Repurchase of own shares on 11.11.2024

November 11, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares11.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 11.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
CSP
2 min read
14

Adopting the final Annual Report

November 11, 2024
0

Reading Time: < 1 minute PHI intends to convene a general meeting to adopt the annual report for the fiscal year 2023/2024 and to amend resolutions regarding election of board members and the number of board members. It has come to the attention of Phase

Continue Reading
CSP
3 min read
20

AnnaCarin Grandin will leave the position as President and CEO of Coor

November 11, 2024
0

Reading Time: 2 minutes After more than four years as President and CEO, AnnaCarin Grandin will leave Coor to take on new challenges outside the company. The Board of Directors will now initiate the process of recruiting a successor. AnnaCarin Grandin will remain in her current

Continue Reading
CSP
2 min read
18

Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook

November 11, 2024
0

Reading Time: < 1 minute Optomed Plc      Inside Information                        11 November 2024 at 21.00, Helsinki Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook Optomed has received a EUR 1.5 million order and increases its full

Continue Reading
CSP
1 min read
16

ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 11.11.2024

November 11, 2024
0

Reading Time: < 1 minute   ALEXANDRIA GROUP OYJ NOTIFICATION     11.11.2024 at 18:30 EET   ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 11.11.2024   Date 11.11.2024   Exchange transaction Buy   Share class ALEX   Amount 250   Average price/share 8.4500 EUR Highest

Continue Reading
CSP
1 min read
16

Fondia Plc: Share repurchase 11.11.2024

November 11, 2024
0

Reading Time: < 1 minute Fondia Plc Company release 11.11.2024 at 6.45 p.m. EET   Fondia – Acquisition of own shares 11.11.2024   Fondia Plc   First North Finland   Date 11.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 93 Average price/share, EUR 5,936559

Continue Reading
CSP
1 min read
13

#24-387 Listing of Derivatives at NGM

November 11, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
2 min read
16

Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (08.11.2024)

November 11, 2024
0

Reading Time: 2 minutes Kesko Corporation has on 11 November 2024 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 8 November 2024, BlackRock, Inc.’s holding in Kesko Corporation, including holding

Continue Reading
CSP
5 min read
12

Norconsult ASA: Settlement of Employee Share Program 2023 (“Gift Shares”)

November 11, 2024
0

Reading Time: 4 minutes Sandvika, 11 November 2024 (OSE: NORCO): Reference is made to the announcement by Norconsult ASA (the “Company”) regarding the Employee Share Program (the “Share Program”) described in the announcement from 10 November 2023 in connection with the Company’s first day of

Continue Reading
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
BWI
4 min read
30

Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise

November 11, 2024
0

Reading Time: 3 minutes Beijing, China & South San Francisco, Calif., United States:   IDEAYA has exercised the option for an exclusive worldwide license on Biocytogen’s potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody-drug conjugate (BsADC), BCG034 (IDE034) This milestone further validates Biocytogen’s proprietary RenLite® antibody

Continue Reading